{
    "2018-02-11": [
        [
            {
                "time": "",
                "original_text": "[领先大市-B评级]医药行业周度报告：《PD1/PDL1单抗上市数据要求》出台 该领域或将重新洗牌",
                "features": {
                    "keywords": [
                        "PD1/PDL1单抗",
                        "上市数据要求",
                        "医药行业",
                        "重新洗牌"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]2018年2月份医药行业投资策略：医药板块中期走强趋势不变 迎战略性加仓机会",
                "features": {
                    "keywords": [
                        "医药板块",
                        "中期走强",
                        "投资策略",
                        "加仓机会"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}